Pfizer Inc (PFE.N)
LONDON AstraZeneca's pill Tagrisso cut the risk of lung cancer progressing by 70 percent compared to standard chemotherapy in a major clinical trial, lifting prospects for a drug that is key to the company's lofty long-term sales goals.
Pfizer Inc said on Monday its cancer drug, Bosulif, was found superior to Novartis AG's Gleevec in a late-stage study on untreated patients with a form of blood and bone marrow cancer characterized by abnormal white blood cells production.
LONDON GlaxoSmithKline said on Monday that Dominique Limet would step down at the end of March 2017 as head of the drugmaker's majority-owned HIV business ViiV Healthcare, to be replaced by GSK insider Deborah Waterhouse.
Pfizer Inc said on Wednesday its experimental biosimilar of Roche Holding AG's blockbuster breast cancer treatment Herceptin was found comparable with the branded version in a key study.
* FDA accepts the biologics license application for Avelumab for the treatment of metastatic merkel cell carcinoma for priority review
FRANKFURT German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek approval to fight a rare and aggressive form of skin cancer with immunotherapy drug avelumab.
FRANKFURT, Nov 29 German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek approval to fight a rare and aggressive form of skin cancer with immunotherapy drug avelumab.
PARIS France's Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent for the time being and will seek co-development deals modeled on an agreement struck with AstraZeneca in April.
BRIEF-QuintilesIMS forms new Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to generate real world insights on usage of anti-cancer therapies across Europe
* Quintilesims forms new collaboration with Bristol-Myers Squibb, Lilly, Merck Kgaa, Darmstadt, Germany, and Pfizer to generate real world insights on usage of anti-cancer therapies across Europe Source text for Eikon: Further company coverage:
Pfizer Inc has sued Texas' health agency, claiming it violated state and federal law by releasing the company's confidential Medicaid rebate information to two state senators.
|Johnson & Johnson (JNJ.N)||$112.00||+0.06|
|Novartis AG (NOVN.S)||CHF69.35||-0.15|
|Merck & Co., Inc. (MRK.N)||$59.99||-0.25|
|Roche Holding Ltd. (ROG.S)||CHF222.50||+0.40|
|Roche Holding Ltd. (RO.S)||CHF226.50||+0.50|
|Abbott Laboratories (ABT.N)||$38.56||+0.14|
|Bayer AG (BAYGn.DE)||€88.16||+0.01|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€75.55||-0.51|
|AstraZeneca plc (AZN.L)||4,037.50p||+4.00|